메뉴 건너뛰기




Volumn 771, Issue , 2013, Pages 288-309

The pancreatic β cells in human type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; EXENDIN 4; GLITAZONE DERIVATIVE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INCRETIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; METFORMIN; ROSIGLITAZONE;

EID: 84874549425     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5441-0_22     Document Type: Article
Times cited : (45)

References (115)
  • 1
    • 78651276631 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; (Suppl 1)34:S62-S69.
    • (2011) Diabetes Care , vol.34 , pp. S62-S69
  • 2
    • 17044386953 scopus 로고    scopus 로고
    • Type 2 diabetes: Principles of pathogenesis and therapy
    • Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005;365:1333-1346.
    • (2005) Lancet , vol.365 , pp. 1333-1346
    • Stumvoll, M.1    Goldstein, B.J.2    Van Haeften, T.W.3
  • 3
    • 0036306096 scopus 로고    scopus 로고
    • American diabetes association GENNID study group: Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S
    • Jensen CC, Cnop M, Hull RL et al. American Diabetes Association GENNID Study Group: Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002; 51:2170-2178.
    • (2002) Diabetes , vol.51 , pp. 2170-2178
    • Jensen, C.C.1    Cnop, M.2    Hull, R.L.3
  • 4
    • 33847636157 scopus 로고    scopus 로고
    • Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes
    • Cnop M, Vidal J, Hull RL et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007; 30:677-682.
    • (2007) Diabetes Care , vol.30 , pp. 677-682
    • Cnop, M.1    Vidal, J.2    Hull, R.L.3
  • 5
    • 0032742992 scopus 로고    scopus 로고
    • The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
    • Weyer C, Bogardus C, Mott DM et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104:787-794.
    • (1999) J Clin Invest , vol.104 , pp. 787-794
    • Weyer, C.1    Bogardus, C.2    Mott, D.M.3
  • 6
    • 33745302884 scopus 로고    scopus 로고
    • The natural course of beta-cell function in nondiabetic and diabetic individuals: The insulin resistance atherosclerosis study
    • Festa A, Williams K, D'Agostino R Jr. et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: the insulin resistance atherosclerosis study. Diabetes 2006; 55:1114-1120.
    • (2006) Diabetes , vol.55 , pp. 1114-1120
    • Festa, A.1    Williams, K.2    D'Agostino, R.3
  • 7
    • 0031961242 scopus 로고    scopus 로고
    • Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: The 10-year follow-up of the Belfast diet study
    • Levy J, Atkinson AB, Bell PM et al. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 1998; 15:290-296.
    • (1998) Diabet Med , vol.15 , pp. 290-296
    • Levy, J.1    Atkinson, A.B.2    Bell, P.M.3
  • 8
    • 0028817815 scopus 로고
    • Overview of 6 years' therapy of type II diabetes: A progressive disease. UK prospective diabetes study group
    • UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes 1995; 44:1249-1258.
    • (1995) Diabetes , vol.44 , pp. 1249-1258
  • 9
    • 0018149835 scopus 로고
    • Islet morphometry in the diabetic pancreas of man
    • Saito K, Takahashi T, Yaginuma N et al. Islet morphometry in the diabetic pancreas of man. Tohoku J Exp Med 1978; 125:185-197.
    • (1978) Tohoku J Exp Med , vol.125 , pp. 185-197
    • Saito, K.1    Takahashi, T.2    Yaginuma, N.3
  • 10
    • 0018146301 scopus 로고
    • The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus
    • Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978; 15:417-421.
    • (1978) Diabetologia , vol.15 , pp. 417-421
    • Westermark, P.1    Wilander, E.2
  • 11
    • 0018641183 scopus 로고
    • Differential volumetry of A, B and D-cells in the pancreatic islets of diabetic and non-diabetic subjects
    • Saito K, Yaginuma N, Takahashi T. Differential volumetry of A, B and D-cells in the pancreatic islets of diabetic and non-diabetic subjects. Tohoku J Exp Med 1979; 129:273-283.
    • (1979) Tohoku J Exp Med , vol.129 , pp. 273-283
    • Saito, K.1    Yaginuma, N.2    Takahashi, T.3
  • 12
    • 0019996086 scopus 로고
    • Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans
    • Stefan Y, Orci L, Malaisse-Lagae F et al. Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 1982; 31:694-700.
    • (1982) Diabetes , vol.31 , pp. 694-700
    • Stefan, Y.1    Orci, L.2    Malaisse-Lagae, F.3
  • 13
    • 0020623615 scopus 로고
    • Cellular composition of the human diabetic pancreas
    • Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia 1983;24:366-371.
    • (1983) Diabetologia , vol.24 , pp. 366-371
    • Rahier, J.1    Goebbels, R.M.2    Henquin, J.C.3
  • 14
    • 0024213009 scopus 로고
    • Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes
    • Clark A, Wells CA, Buley ID et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988; 9:151-159.
    • (1988) Diabetes Res , vol.9 , pp. 151-159
    • Clark, A.1    Wells, C.A.2    Buley, I.D.3
  • 15
    • 0036163156 scopus 로고    scopus 로고
    • Reduced beta cell mass and expression of oxidative stress related DNA damage in the islets of Japanese type 2 diabetic patients
    • Sakuraba H, Mizukami H, Yagihashi N et al. Reduced beta cell mass and expression of oxidative stress related DNA damage in the islets of Japanese type 2 diabetic patients. Diabetologia 2002; 45:85-96.
    • (2002) Diabetologia , vol.45 , pp. 85-96
    • Sakuraba, H.1    Mizukami, H.2    Yagihashi, N.3
  • 16
    • 0038707331 scopus 로고    scopus 로고
    • Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea
    • Yoon KH, Ko SH, Cho JH et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea. J Clin Endocrinol Metab 2003; 88:2300-2308.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 2300-2308
    • Yoon, K.H.1    Ko, S.H.2    Cho, J.H.3
  • 17
    • 0037219411 scopus 로고    scopus 로고
    • Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
    • Butler AE, Janson J, Bonner-Weir S et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52:102-110.
    • (2003) Diabetes , vol.52 , pp. 102-110
    • Butler, A.E.1    Janson, J.2    Bonner-Weir, S.3
  • 18
    • 43549100675 scopus 로고    scopus 로고
    • Islet amyloid in type 2 diabetes and the toxic oligomer hypothesis
    • Haataja L, Gurlo T, Huang CJ et al. Islet amyloid in type 2 diabetes and the toxic oligomer hypothesis. Endocr Rev 2008;29:303-316.
    • (2008) Endocr Rev , vol.29 , pp. 303-316
    • Haataja, L.1    Gurlo, T.2    Huang, C.J.3
  • 19
    • 53549093011 scopus 로고    scopus 로고
    • Pancreatic beta-cell mass in European subjects with type 2 diabetes
    • Rahier J, Guiot Y, Goebbels RM et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10(Suppl 4):32-42.
    • (2008) Diabetes Obes Metab , vol.10 , pp. 32-42
    • Rahier, J.1    Guiot, Y.2    Goebbels, R.M.3
  • 20
    • 77950290798 scopus 로고    scopus 로고
    • Beta-cell mass dynamics and islet cell plasticity in human type 2 diabetes
    • Hanley SC, Austin E, Assouline-Thomas B et al. Beta-cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 2010; 151:1462-1472.
    • (2010) Endocrinology , vol.151 , pp. 1462-1472
    • Hanley, S.C.1    Austin, E.2    Assouline-Thomas, B.3
  • 21
    • 35848963392 scopus 로고    scopus 로고
    • The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
    • Marchetti P, Bugliani M, Lupi R et al. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 2007; 50:2486-2494.
    • (2007) Diabetologia , vol.50 , pp. 2486-2494
    • Marchetti, P.1    Bugliani, M.2    Lupi, R.3
  • 22
    • 8744272467 scopus 로고    scopus 로고
    • Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin
    • Marchetti P, Del Guerra S, Marselli L et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 2004; 89:5535-5541.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 5535-5541
    • Marchetti, P.1    Del Guerra, S.2    Marselli, L.3
  • 23
    • 33847677975 scopus 로고    scopus 로고
    • Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
    • Laybutt DR, Preston AM, Åkerfeldt MC et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007; 50:752-763.
    • (2007) Diabetologia , vol.50 , pp. 752-763
    • Laybutt, D.R.1    Preston, A.M.2    Åkerfeldt, M.C.3
  • 24
    • 22544432640 scopus 로고    scopus 로고
    • Nomenclature committee on cell death: Classification of cell death: Recommendations of the nomenclature committee on cell death
    • Kroemer G, El-Deiry WS, Golstein P et al. Nomenclature committee on cell death: classification of cell death: recommendations of the nomenclature committee on cell death. Cell Death Differ 2005; 12(Suppl 2): 1463-1467.
    • (2005) Cell Death Differ , vol.12 , pp. 1463-1467
    • Kroemer, G.1    El-Deiry, W.S.2    Golstein, P.3
  • 25
    • 33750292972 scopus 로고    scopus 로고
    • Cell death in nervous system
    • Bredesen DE, Rao RV, Mehlen P. Cell death in nervous system. Nature 2006; 443:796-802.
    • (2006) Nature , vol.443 , pp. 796-802
    • Bredesen, D.E.1    Rao, R.V.2    Mehlen, P.3
  • 26
    • 27644466759 scopus 로고    scopus 로고
    • Autophagy and signaling: Their role in cell survival and cell death
    • Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 2005; 12(Suppl 2):1509-1518.
    • (2005) Cell Death Differ , vol.12 , pp. 1509-1518
    • Codogno, P.1    Meijer, A.J.2
  • 27
    • 67349150186 scopus 로고    scopus 로고
    • Autophagy in human type 2 diabetes pancreatic beta cells
    • Masini M, Bugliani M, Lupi R et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 2009;52:1083-1086.
    • (2009) Diabetologia , vol.52 , pp. 1083-1086
    • Masini, M.1    Bugliani, M.2    Lupi, R.3
  • 28
    • 2342457712 scopus 로고    scopus 로고
    • Beta cell differentiation during early human pancreas development
    • Piper K, Brickwood S, Turnpenny LW et al. Beta cell differentiation during early human pancreas development. J Endocrinol 2004; 181:11-23.
    • (2004) J Endocrinol , vol.181 , pp. 11-23
    • Piper, K.1    Brickwood, S.2    Turnpenny, L.W.3
  • 29
    • 77149127706 scopus 로고    scopus 로고
    • Beta-cell development and turnover during prenatal life in humans
    • Meier JJ, Kohler CU, Alkhatib B et al. Beta-cell development and turnover during prenatal life in humans. Eur J Endocrinol 2010; 152:559-568.
    • (2010) Eur J Endocrinol , vol.152 , pp. 559-568
    • Meier, J.J.1    Kohler, C.U.2    Alkhatib, B.3
  • 30
    • 0033853921 scopus 로고    scopus 로고
    • Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
    • Kassem SA, Ariel I, Thornton PS et al. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000; 49:1325-1333.
    • (2000) Diabetes , vol.49 , pp. 1325-1333
    • Kassem, S.A.1    Ariel, I.2    Thornton, P.S.3
  • 31
    • 44749088201 scopus 로고    scopus 로고
    • Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans
    • Meier JJ, Butler AE, Saisho Y et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008; 57:1584-1594.
    • (2008) Diabetes , vol.57 , pp. 1584-1594
    • Meier, J.J.1    Butler, A.E.2    Saisho, Y.3
  • 32
    • 77949289481 scopus 로고    scopus 로고
    • The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation
    • Cnop M, Hughes SJ, Igoillo-Esteve M et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 2010; 53:321-330.
    • (2010) Diabetologia , vol.53 , pp. 321-330
    • Cnop, M.1    Hughes, S.J.2    Igoillo-Esteve, M.3
  • 33
    • 77957787230 scopus 로고    scopus 로고
    • Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating
    • Perl S, Kushner JA, Buchholz BA et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 2010; 95:E234-E239.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. E234-E239
    • Perl, S.1    Kushner, J.A.2    Buchholz, B.A.3
  • 34
    • 77958040076 scopus 로고    scopus 로고
    • Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy
    • Butler AE, Cao-Minh L, Galasso R et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53:2167-2176.
    • (2010) Diabetologia , vol.53 , pp. 2167-2176
    • Butler, A.E.1    Cao-Minh, L.2    Galasso, R.3
  • 35
    • 80052737348 scopus 로고    scopus 로고
    • Histopathology and ex vivo insulin secretion of pancreatic islets in gestational diabetes. A case report
    • in press
    • Tancredi M, Marselli L, Lencioni C et al. Histopathology and ex vivo insulin secretion of pancreatic islets in gestational diabetes. A case report. Islets 2011, in press.
    • (2011) Islets
    • Tancredi, M.1    Marselli, L.2    Lencioni, C.3
  • 36
    • 58649120819 scopus 로고    scopus 로고
    • Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis
    • Schrader H, Menge BA, Schneider S et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology 2009; 136:513-522.
    • (2009) Gastroenterology , vol.136 , pp. 513-522
    • Schrader, H.1    Menge, B.A.2    Schneider, S.3
  • 37
    • 58149477520 scopus 로고    scopus 로고
    • Metabolic consequences of a 50% partial pancreatectomy in humans
    • Menge BA, Schrader H, Breuer TG. Metabolic consequences of a 50% partial pancreatectomy in humans. Diabetologia 2009; 52:306-317.
    • (2009) Diabetologia , vol.52 , pp. 306-317
    • Menge, B.A.1    Schrader, H.2    Breuer, T.G.3
  • 38
    • 0026447606 scopus 로고
    • Pancreatic exocrine and endocrine function after operations for chronic pancreatitis
    • Jalleh RP, Williamson RC. Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg 1992; 216:656-662.
    • (1992) Ann Surg , vol.216 , pp. 656-662
    • Jalleh, R.P.1    Williamson, R.C.2
  • 39
    • 0025357136 scopus 로고
    • Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head
    • Beger HG, Buchler M. Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head. World J Surg 1990; 14:83-87.
    • (1990) World J Surg , vol.14 , pp. 83-87
    • Beger, H.G.1    Buchler, M.2
  • 40
    • 79551705360 scopus 로고    scopus 로고
    • Segmental live donor pancreas transplantation: Review and critique of rationale, outcomes and current recommendations
    • Boggi U, Amorese G, Marchetti P et al. Segmental live donor pancreas transplantation: review and critique of rationale, outcomes and current recommendations. Clin Transplant 2011; 25:4-12.
    • (2011) Clin Transplant , vol.25 , pp. 4-12
    • Boggi, U.1    Amorese, G.2    Marchetti, P.3
  • 41
    • 0025342504 scopus 로고
    • Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans
    • Kendall DM, Sutherland DE, Najarian JS et al. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 1990; 322:898-903.
    • (1990) N Engl J Med , vol.322 , pp. 898-903
    • Kendall, D.M.1    Sutherland, D.E.2    Najarian, J.S.3
  • 42
    • 49649125936 scopus 로고    scopus 로고
    • Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism
    • Kumar AF, Gruessner RW, Seaquist ER. Risk of glucose intolerance and diabetes in hemipancreatectomized donors selected for normal preoperative glucose metabolism. Diabetes Care 2008; 31:1639-1643.
    • (2008) Diabetes Care , vol.31 , pp. 1639-1643
    • Kumar, A.F.1    Gruessner, R.W.2    Seaquist, E.R.3
  • 43
    • 0028057533 scopus 로고
    • Enzymatic, metabolic and secretory patterns in human islets of type 2 (noninsulin-dependent) diabetic patients
    • Fernandez-Alvarez J, Conget I, Rasschaert J et al. Enzymatic, metabolic and secretory patterns in human islets of type 2 (noninsulin-dependent) diabetic patients. Diabetologia 1994; 37:177-181.
    • (1994) Diabetologia , vol.37 , pp. 177-181
    • Fernandez-Alvarez, J.1    Conget, I.2    Rasschaert, J.3
  • 44
    • 10744222060 scopus 로고    scopus 로고
    • Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects
    • Deng S, Vatamaniuk M, Huang X et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004; 53:624-632.
    • (2004) Diabetes , vol.53 , pp. 624-632
    • Deng, S.1    Vatamaniuk, M.2    Huang, X.3
  • 45
    • 20044390365 scopus 로고    scopus 로고
    • Functional and molecular defects of pancreatic islets in human type 2 diabetes
    • Del Guerra S, Lupi R, Marselli L et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005; 54:727-735.
    • (2005) Diabetes , vol.54 , pp. 727-735
    • Del Guerra, S.1    Lupi, R.2    Marselli, L.3
  • 46
    • 38149042694 scopus 로고    scopus 로고
    • An overview of pancreatic beta-cell defects in human type 2 diabetes: Implications for treatment
    • Marchetti P, Dotta F, Lauro D et al. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 2008; 146:4-11.
    • (2008) Regul Pept , vol.146 , pp. 4-11
    • Marchetti, P.1    Dotta, F.2    Lauro, D.3
  • 47
    • 20244376316 scopus 로고    scopus 로고
    • Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients
    • Anello M, Lupi R, Spampinato D et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 2005; 48:282-289.
    • (2005) Diabetologia , vol.48 , pp. 282-289
    • Anello, M.1    Lupi, R.2    Spampinato, D.3
  • 48
    • 23744439083 scopus 로고    scopus 로고
    • Loss of ARNT/HIFlbeta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
    • Gunton JE, Kulkarni RN, Yim S et al. Loss of ARNT/HIFlbeta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005; 122:337-349.
    • (2005) Cell , vol.122 , pp. 337-349
    • Gunton, J.E.1    Kulkarni, R.N.2    Yim, S.3
  • 49
    • 33644772589 scopus 로고    scopus 로고
    • Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients
    • Ostenson CG, Gaisano H, Sheu L et al. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes 2006; 55:435-440.
    • (2006) Diabetes , vol.55 , pp. 435-440
    • Ostenson, C.G.1    Gaisano, H.2    Sheu, L.3
  • 50
    • 38849135820 scopus 로고    scopus 로고
    • The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1
    • Brun T, Hu He KH, Lupi R et al. The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. Hum Mol Genet 2008; 17:478-489.
    • (2008) Hum Mol Genet , vol.17 , pp. 478-489
    • Brun, T.1    Hu He, K.H.2    Lupi, R.3
  • 51
    • 34547702501 scopus 로고    scopus 로고
    • Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
    • Lyssenko V, Lupi R, Marchetti P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117:2155-2163.
    • (2007) J Clin Invest , vol.117 , pp. 2155-2163
    • Lyssenko, V.1    Lupi, R.2    Marchetti, P.3
  • 52
    • 40849111440 scopus 로고    scopus 로고
    • Gene expression of purified beta cell tissue obtained from human pancreas with laser capture microdissection
    • Marselli L, Thorne J, Ahn YB et al. Gene expression of purified beta cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008; 93:1045-1053.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 1045-1053
    • Marselli, L.1    Thorne, J.2    Ahn, Y.B.3
  • 53
    • 77955364191 scopus 로고    scopus 로고
    • Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes
    • Marselli L, Thorne J, Dahiya S et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One 2010; 5(7):ell499.
    • (2010) PLoS One , vol.5 , Issue.7 , pp. ell499
    • Marselli, L.1    Thorne, J.2    Dahiya, S.3
  • 54
    • 67249096093 scopus 로고    scopus 로고
    • Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
    • Shu L, Matveyenko AV, Kerr-Conte J et al. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009; 18:2388-2299.
    • (2009) Hum Mol Genet , vol.18 , pp. 2388-2299
    • Shu, L.1    Matveyenko, A.V.2    Kerr-Conte, J.3
  • 55
    • 71549166982 scopus 로고    scopus 로고
    • Apoptotic, regenerative and immune-related signaling in human islets from type 2 diabetes individuals
    • Nyblom HK, Bugliani M, Fung E et al. Apoptotic, regenerative and immune-related signaling in human islets from type 2 diabetes individuals. J Proteome Res 2009; 8:5650-5656.
    • (2009) J Proteome Res , vol.8 , pp. 5650-5656
    • Nyblom, H.K.1    Bugliani, M.2    Fung, E.3
  • 56
    • 78649842241 scopus 로고    scopus 로고
    • Genomics, type 2 diabetes and obesity
    • McCarthy MI. Genomics, type 2 diabetes and obesity. N Engl J Med 2010; 363:2339-2350.
    • (2010) N Engl J Med , vol.363 , pp. 2339-2350
    • McCarthy, M.I.1
  • 57
    • 52649133436 scopus 로고    scopus 로고
    • Genes and type 2 diabetes mellitus
    • Groop L, Lyssenko V. Genes and type 2 diabetes mellitus. Curr Diab Rep 2008; 8:192-197.
    • (2008) Curr Diab Rep , vol.8 , pp. 192-197
    • Groop, L.1    Lyssenko, V.2
  • 59
    • 0036319044 scopus 로고    scopus 로고
    • Insulin secretory function is impaired in isolated human islets carrying the Gly(972)->Arg IRS-1 polymorphism
    • Marchetti P, Lupi R, Federici M et al. Insulin secretory function is impaired in isolated human islets carrying the Gly(972)->Arg IRS-1 polymorphism. Diabetes 2002; 51:1419-1424.
    • (2002) Diabetes , vol.51 , pp. 1419-1424
    • Marchetti, P.1    Lupi, R.2    Federici, M.3
  • 60
    • 0035220244 scopus 로고    scopus 로고
    • The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets
    • Federici M, Hribal ML, Ranalli M et al. The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 2001; 15:22-24.
    • (2001) FASEB J , vol.15 , pp. 22-24
    • Federici, M.1    Hribal, M.L.2    Ranalli, M.3
  • 61
    • 79955872917 scopus 로고    scopus 로고
    • ENPP1 affects insulin action and secretion: Evidences from in vitro studies
    • Di Paola R, Caporarello N, Marucci A et al. ENPP1 affects insulin action and secretion: evidences from in vitro studies. PLoS One 2011; 6:el9462.
    • (2011) PLoS One , vol.6 , pp. el9462
    • Di Paola, R.1    Caporarello, N.2    Marucci, A.3
  • 62
    • 58149389465 scopus 로고    scopus 로고
    • The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes
    • Prudente S, Scarpelli D, Chandalia M et al. The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab 2009; 94:190-196.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 190-196
    • Prudente, S.1    Scarpelli, D.2    Chandalia, M.3
  • 63
    • 61849101938 scopus 로고    scopus 로고
    • Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: A large human genome epidemiology (HuGE) review and meta-analysis
    • Tong Y, Lin Y, Zhang Y et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009; 10:15.
    • (2009) BMC Med Genet , vol.10 , pp. 15
    • Tong, Y.1    Lin, Y.2    Zhang, Y.3
  • 64
    • 40949141938 scopus 로고    scopus 로고
    • Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets
    • Shu L, Sauter NS, Schulthess FT et al. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008; 57:645-653.
    • (2008) Diabetes , vol.57 , pp. 645-653
    • Shu, L.1    Sauter, N.S.2    Schulthess, F.T.3
  • 65
    • 58149175669 scopus 로고    scopus 로고
    • Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion
    • Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009; 4:82-88.
    • (2009) Nat Genet , vol.4 , pp. 82-88
    • Lyssenko, V.1    Nagorny, C.L.2    Erdos, M.R.3
  • 66
    • 68949213757 scopus 로고    scopus 로고
    • Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes
    • Ling C, Groop L, Guerra SD et al. Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes. PLoS One 2009; 18;4(8):e6558.
    • (2009) PLoS One , vol.18 , Issue.4-8 , pp. e6558
    • Ling, C.1    Groop, L.2    Guerra, S.D.3
  • 67
    • 12444292715 scopus 로고    scopus 로고
    • A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects
    • Sesti G, Cardellini M, Marini MA et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 2003; 52:1280-1283.
    • (2003) Diabetes , vol.52 , pp. 1280-1283
    • Sesti, G.1    Cardellini, M.2    Marini, M.A.3
  • 68
    • 33744965950 scopus 로고    scopus 로고
    • The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes
    • Sesti G, Laratta E, Cardellini M et al. The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 2006; 91:2334-2339.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 2334-2339
    • Sesti, G.1    Laratta, E.2    Cardellini, M.3
  • 69
    • 77950520084 scopus 로고    scopus 로고
    • Meta-analysis and functional effects of the SLC30A8 rs 13266634 polymorphism on isolated human pancreatic islets
    • Cauchi S, Del Guerra S, Choquet H et al. Meta-analysis and functional effects of the SLC30A8 rs 13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab 2010; 100:77-82.
    • (2010) Mol Genet Metab , vol.100 , pp. 77-82
    • Cauchi, S.1    Del Guerra, S.2    Choquet, H.3
  • 70
    • 0034982387 scopus 로고    scopus 로고
    • High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: A potential role for regulation of specific Bel family genes toward an apoptotic cell death program
    • Federici M, Hribal M, Perego L et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bel family genes toward an apoptotic cell death program. Diabetes 2001; 50:1290-2301.
    • (2001) Diabetes , vol.50 , pp. 1290-2301
    • Federici, M.1    Hribal, M.2    Perego, L.3
  • 71
    • 6944246692 scopus 로고    scopus 로고
    • Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells
    • D'Alessandris C, Andreozzi F, Federici M et al. Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells. FASEB J 2004;18:959-961.
    • (2004) FASEB J , vol.18 , pp. 959-961
    • D'Alessandris, C.1    Andreozzi, F.2    Federici, M.3
  • 72
    • 33750502270 scopus 로고    scopus 로고
    • Oxidative stress and impaired insulin secretion in type 2 diabetes
    • Robertson RP. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 2006;6:615-619.
    • (2006) Curr Opin Pharmacol , vol.6 , pp. 615-619
    • Robertson, R.P.1
  • 73
    • 70349254097 scopus 로고    scopus 로고
    • Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide
    • Del Guerra S, D'Aleo V, Lupi R et al. Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. Diabetes Metab 2009; 35:293-298.
    • (2009) Diabetes Metab , vol.35 , pp. 293-298
    • Del Guerra, S.1    D'Aleo, V.2    Lupi, R.3
  • 74
    • 0026033901 scopus 로고
    • Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: Partial reversibility after an additional culture in a normal glucose medium
    • Davalli AM, Ricordi C, Socci C et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 1991; 72:202-208.
    • (1991) J Clin Endocrinol Metab , vol.72 , pp. 202-208
    • Davalli, A.M.1    Ricordi, C.2    Socci, C.3
  • 75
    • 70350330155 scopus 로고    scopus 로고
    • Towards better understanding of the contributions of overwork and glucotoxicity to the beta cell inadequacy of type 2 diabetes
    • Weir GC, Marselli L, Marchetti P et al. Towards better understanding of the contributions of overwork and glucotoxicity to the beta cell inadequacy of type 2 diabetes. Diabetes Obes Metab 2009; 11(Suppl 4): 82-90.
    • (2009) Diabetes Obes Metab , vol.11 , pp. 82-90
    • Weir, G.C.1    Marselli, L.2    Marchetti, P.3
  • 76
    • 0032921702 scopus 로고    scopus 로고
    • The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose
    • Lupi R, Del Guerra S, Tellini C et al. The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose. Eur J Pharmacol 1999; 364:205-209.
    • (1999) Eur J Pharmacol , vol.364 , pp. 205-209
    • Lupi, R.1    Del Guerra, S.2    Tellini, C.3
  • 77
    • 5644248079 scopus 로고    scopus 로고
    • Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes
    • Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279:42351-42354.
    • (2004) J Biol Chem , vol.279 , pp. 42351-42354
    • Robertson, R.P.1
  • 78
    • 45249089262 scopus 로고    scopus 로고
    • Oxidative stress: The vulnerable beta-cell
    • Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 2008; 36:343-347.
    • (2008) Biochem Soc Trans , vol.36 , pp. 343-347
    • Lenzen, S.1
  • 79
    • 34447504557 scopus 로고    scopus 로고
    • Pancreatic islet beta-cell and oxidative stress: The importance of glutathione peroxidase
    • Robertson RP, Harmon JS. Pancreatic islet beta-cell and oxidative stress: the importance of glutathione peroxidase. FEBS Lett 2007; 581:3743-3748.
    • (2007) FEBS Lett , vol.581 , pp. 3743-3748
    • Robertson, R.P.1    Harmon, J.S.2
  • 80
    • 0019852821 scopus 로고
    • CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse
    • Grankvist K, Marklund SL, Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 1981; 199: 393-398.
    • (1981) Biochem J , vol.199 , pp. 393-398
    • Grankvist, K.1    Marklund, S.L.2    Taljedal, I.B.3
  • 81
    • 0037341238 scopus 로고    scopus 로고
    • Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad and the glutathione connection
    • Robertson RP, Harmon J, Tran PO et al. Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad and the glutathione connection. Diabetes 2003; 52:581-587.
    • (2003) Diabetes , vol.52 , pp. 581-587
    • Robertson, R.P.1    Harmon, J.2    Tran, P.O.3
  • 82
    • 35848941295 scopus 로고    scopus 로고
    • Glutathione peroxidase protein expression and activity in human islets isolated for transplantation
    • Tonooka N, Oseid E, Zhou H et al. Glutathione peroxidase protein expression and activity in human islets isolated for transplantation. Clin Transplant 2007; 21:767-772.
    • (2007) Clin Transplant , vol.21 , pp. 767-772
    • Tonooka, N.1    Oseid, E.2    Zhou, H.3
  • 83
    • 0029401861 scopus 로고
    • Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: Implications for the pathogenesis of insulin-dependent diabetes mellitus
    • Welsh N, Margulis B, Borg LA et al. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med 1995; 1:806-820.
    • (1995) Mol Med , vol.1 , pp. 806-820
    • Welsh, N.1    Margulis, B.2    Borg, L.A.3
  • 84
    • 0141755328 scopus 로고    scopus 로고
    • A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
    • Kashyap S, Belfort R, Gastaldelli A et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003; 52:2461-2474.
    • (2003) Diabetes , vol.52 , pp. 2461-2474
    • Kashyap, S.1    Belfort, R.2    Gastaldelli, A.3
  • 85
    • 79251585927 scopus 로고    scopus 로고
    • Lipid-induced pancreatic β-cell dysfunction: Focus on in vivo studies
    • Giacca A, Xiao C, Oprescu AI et al. Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 2011; 300:E255-E262.
    • (2011) Am J Physiol Endocrinol Metab , vol.300 , pp. E255-E262
    • Giacca, A.1    Xiao, C.2    Oprescu, A.I.3
  • 86
    • 0036315888 scopus 로고    scopus 로고
    • Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway and Bel-2 regulated
    • Lupi R, Dotta F, Marselli L et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway and Bel-2 regulated. Diabetes 2002; 51:1437-1442.
    • (2002) Diabetes , vol.51 , pp. 1437-1442
    • Lupi, R.1    Dotta, F.2    Marselli, L.3
  • 87
    • 0345354674 scopus 로고    scopus 로고
    • Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function
    • Maedler K, Oberholzer J, Bucher P et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 2003; 52:726-733.
    • (2003) Diabetes , vol.52 , pp. 726-733
    • Maedler, K.1    Oberholzer, J.2    Bucher, P.3
  • 88
    • 0036924861 scopus 로고    scopus 로고
    • Different role of saturated and unsaturated fatty acids in beta-cell apoptosis
    • Eitel K, Staiger H, Brendel MD et al. Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 2002; 299:853-856.
    • (2002) Biochem Biophys Res Commun , vol.299 , pp. 853-856
    • Eitel, K.1    Staiger, H.2    Brendel, M.D.3
  • 89
    • 0042922453 scopus 로고    scopus 로고
    • Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death
    • El-Assaad W, Buteau J, Peyot ML et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 2003; 144:4154-4163.
    • (2003) Endocrinology , vol.144 , pp. 4154-4163
    • El-Assaad, W.1    Buteau, J.2    Peyot, M.L.3
  • 90
    • 0029036835 scopus 로고
    • Long-term exposure to fatty acids and ketones inhibits beta-cell function in human pancreatic islets of Langerhans
    • Zhou YP, Grill V. Long-term exposure to fatty acids and ketones inhibits beta-cell function in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 1995; 80:1584-1590.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 1584-1590
    • Zhou, Y.P.1    Grill, V.2
  • 91
    • 50549202600 scopus 로고
    • The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
    • Randle PJ, Garland PB, Hales CN et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 13:785-789.
    • (1963) Lancet , vol.13 , pp. 785-789
    • Randle, P.J.1    Garland, P.B.2    Hales, C.N.3
  • 92
    • 11144354264 scopus 로고    scopus 로고
    • Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration
    • Bouckenooghe T, Muharram G, D'Herbomez M et al. Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration. Diabetologia 2004; 47:463-469.
    • (2004) Diabetologia , vol.47 , pp. 463-469
    • Bouckenooghe, T.1    Muharram, G.2    D'Herbomez, M.3
  • 93
    • 0036318319 scopus 로고    scopus 로고
    • Lipotoxicity in human pancreatic islets and the protective effect of metformin
    • Lupi R, Del Guerra S, Fierabracci V et al. Lipotoxicity in human pancreatic islets and the protective effect of metformin. Diabetes 2002; 51(Suppl 1):134-137.
    • (2002) Diabetes , vol.51 , pp. 134-137
    • Lupi, R.1    Del Guerra, S.2    Fierabracci, V.3
  • 94
    • 49649084031 scopus 로고    scopus 로고
    • Initiation and execution of lipotoxic ER stress in pancreatic beta-cells
    • Cunha DA, Hekerman P, Ladriere L et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 2008; 121:2308-2318.
    • (2008) J Cell Sci , vol.121 , pp. 2308-2318
    • Cunha, D.A.1    Hekerman, P.2    Ladriere, L.3
  • 95
    • 1642414416 scopus 로고    scopus 로고
    • Rosiglitazone prevents the impairment of human islet function induced by fatty acids: Evidence for a role of PPAR gamma2 in the modulation of insulin secretion
    • Lupi R, Del Guerra S, Marselli L et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR gamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004; 286:E560-E567.
    • (2004) Am J Physiol Endocrinol Metab , vol.286 , pp. E560-E567
    • Lupi, R.1    Del Guerra, S.2    Marselli, L.3
  • 96
    • 73249116246 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through up regulation of BiP and JunB
    • Cunha DA, Ladriere L, Ortis F et al. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through up regulation of BiP and JunB. Diabetes 2009; 58:2851-2862.
    • (2009) Diabetes , vol.58 , pp. 2851-2862
    • Cunha, D.A.1    Ladriere, L.2    Ortis, F.3
  • 98
    • 33847012626 scopus 로고    scopus 로고
    • Human islet amyloid polypeptide oligormers disrupt cell coupling, induce apoptosis and impair insulin secretion in isolated human islets
    • Ritzel RA, Meier JJ, Lin CY et al. Human islet amyloid polypeptide oligormers disrupt cell coupling, induce apoptosis and impair insulin secretion in isolated human islets. Diabetes 2007; 56:65-71.
    • (2007) Diabetes , vol.56 , pp. 65-71
    • Ritzel, R.A.1    Meier, J.J.2    Lin, C.Y.3
  • 99
    • 0023192941 scopus 로고
    • Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuopeptide-like protein also present in normal islet cells
    • Westermark P, Wernstedt C, Wilander E et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuopeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A 1987; 84:3881-3885.
    • (1987) Proc Natl Acad Sci U S A , vol.84 , pp. 3881-3885
    • Westermark, P.1    Wernstedt, C.2    Wilander, E.3
  • 100
    • 0023579739 scopus 로고
    • Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients
    • Cooper GJ, Willis AC, Clark A et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 1987; 84:8628-8632.
    • (1987) Proc Natl Acad Sci U S A , vol.84 , pp. 8628-8632
    • Cooper, G.J.1    Willis, A.C.2    Clark, A.3
  • 101
    • 0038015599 scopus 로고    scopus 로고
    • Replication increases beta cell vulnerability to human islet amyloid polypeptide-induced apoptosis
    • Ritzel RA, Butler PC. Replication increases beta cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 2003; 52:1701-1708.
    • (2003) Diabetes , vol.52 , pp. 1701-1708
    • Ritzel, R.A.1    Butler, P.C.2
  • 102
    • 33845467504 scopus 로고    scopus 로고
    • Inhibition of human IAPP fibril formation does not prevent beta cell death: Evidence for distinct actions of oligomers and fibrils of human IAPP
    • Meier JJ, Kayed R, Lin CY et al. Inhibition of human IAPP fibril formation does not prevent beta cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab 2006; 291:E1317-E1324.
    • (2006) Am J Physiol Endocrinol Metab , vol.291 , pp. E1317-E1324
    • Meier, J.J.1    Kayed, R.2    Lin, C.Y.3
  • 103
    • 76149102617 scopus 로고    scopus 로고
    • Evidence for proteotoxicity in beta cells in type 2 diabetes: Toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway
    • Gurlo T, Ryazantsev S, Huang CJ et al. Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol 2010; 176:861-869.
    • (2010) Am J Pathol , vol.176 , pp. 861-869
    • Gurlo, T.1    Ryazantsev, S.2    Huang, C.J.3
  • 104
    • 28744444020 scopus 로고    scopus 로고
    • Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway
    • Lin CY, Gurlo T, Haataja L et al. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 2005; 90:6678-6686.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 6678-6686
    • Lin, C.Y.1    Gurlo, T.2    Haataja, L.3
  • 105
    • 53749100698 scopus 로고    scopus 로고
    • Increased interleukin (IL)-1 beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1 beta in human islets by glucose and auto stimulation
    • Boni-Schnetzler M, Thorne J, Parnaud G et al. Increased interleukin (IL)-1 beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1 beta in human islets by glucose and auto stimulation. J Clin Endocrinol Metab 2008; 93:4065-4074.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 4065-4074
    • Boni-Schnetzler, M.1    Thorne, J.2    Parnaud, G.3
  • 106
    • 45249119338 scopus 로고    scopus 로고
    • Macrophages, cytokines and beta-cell death in Type 2 diabetes
    • Ehses JA, Boni-Schnetzler M, Faulenbach M et al. Macrophages, cytokines and beta-cell death in Type 2 diabetes. Biochem Soc Trans 2008; 36:340-342.
    • (2008) Biochem Soc Trans , vol.36 , pp. 340-342
    • Ehses, J.A.1    Boni-Schnetzler, M.2    Faulenbach, M.3
  • 107
    • 67650685521 scopus 로고    scopus 로고
    • Islet-associated macrophages in type 2 diabetes
    • Richardson SJ, Willcox A, Bone AJ et al. Islet-associated macrophages in type 2 diabetes. Diabetologia 2009; 52:1686-1688.
    • (2009) Diabetologia , vol.52 , pp. 1686-1688
    • Richardson, S.J.1    Willcox, A.2    Bone, A.J.3
  • 108
    • 33644669584 scopus 로고    scopus 로고
    • Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?
    • Welsh N, Cnop M, Kharroubi I et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 2005; 54: 3238-3244.
    • (2005) Diabetes , vol.54 , pp. 3238-3244
    • Welsh, N.1    Cnop, M.2    Kharroubi, I.3
  • 109
    • 77955658618 scopus 로고    scopus 로고
    • Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
    • Igoillo-Esteve M, Marselli L, Cunha DA et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 2010; 53:1395-1405.
    • (2010) Diabetologia , vol.53 , pp. 1395-1405
    • Igoillo-Esteve, M.1    Marselli, L.2    Cunha, D.A.3
  • 110
    • 34247170807 scopus 로고    scopus 로고
    • Interleukin-1-receptor antagonist in type 2 diabetes mellitus
    • Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356:1517-1526.
    • (2007) N Engl J Med , vol.356 , pp. 1517-1526
    • Larsen, C.M.1    Faulenbach, M.2    Vaag, A.3
  • 111
    • 75549088122 scopus 로고    scopus 로고
    • Goals of treatment for type 2 diabetes: Beta-cell preservation for glycemic control
    • Marchetti P, Lupi R, Del Guerra S et al. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care 2009; 32 (Suppl 2):S178-S183.
    • (2009) Diabetes Care , vol.32 , pp. S178-S183
    • Marchetti, P.1    Lupi, R.2    Del Guerra, S.3
  • 112
    • 35649013806 scopus 로고    scopus 로고
    • Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger
    • Lupi R, Del Guerra S, Mancarella R et al. Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. Diabetes Metab 2007; 33:340-345.
    • (2007) Diabetes Metab , vol.33 , pp. 340-345
    • Lupi, R.1    Del Guerra, S.2    Mancarella, R.3
  • 113
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: Glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • Drucker DJ, Nauck MA. The incretin system: glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368:1696-1705.
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 115
    • 43149088031 scopus 로고    scopus 로고
    • Effects of exendin-4 on islets from type 2 diabetes patients
    • Lupi R, Mancarella R, Del Guerra S et al. Effects of exendin-4 on islets from type 2 diabetes patients. Diabetes Obes Metab 2008; 10:515-519.
    • (2008) Diabetes Obes Metab , vol.10 , pp. 515-519
    • Lupi, R.1    Mancarella, R.2    Del Guerra, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.